kl01013.htm  


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
 
                   
 
Under the Securities Exchange Act of 1934
 
SCHEDULE 13G
(AMENDMENT)

INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
Vishay Intertechnology, Inc.
(Name of Issuer)
 
    Common Stock, par value $0.10 per share    
(Title of Class of Securities)
 
       928298108       
(CUSIP Number)

 
                  December 31, 2010                 
(Date of Event Which Requires Filing of this Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
¨  Rule 13d-1(b)
¨  Rule 13d-1(c)
ý  Rule 13d-1(d)


Page 1 of  6 Pages

 
 
 

SCHEDULE 13G
 
CUSIP No. 928298108                                                      Page 2 of 6 Pages
 
1)
NAME OF REPORTING PERSON
 
Dr. Felix Zandman
 
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
2)
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)       ¨
(b)       ¨
3)
SEC USE ONLY
 
 
4)
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5)
SOLE VOTING POWER
 
6,419,371
6)
SHARED VOTING POWER
 
8,000,100
7)
SOLE DISPOSITIVE POWER
 
774,889
8)
SHARED DISPOSITIVE POWER
 
8,000,100
9)
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
14,419,471
10)
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
¨
11)
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
8.7%
12)
TYPE OF REPORTING PERSON
 
IN
 

 
 
 
 

Schedule 13G
 
Item 1(a).
Name of Issuer:
 
 
Vishay Intertechnology, Inc.
 
Item 1(b).
Address of Issuer’s Principal Executive Offices:
 
63 Lancaster Avenue
Malvern, Pennsylvania  19355-2143
 
Item 2(a).
Name of Person Filing:

 
Dr. Felix Zandman
 
Item 2(b).
Address of Principal Business Office or, if None, Residence:
 
63 Lancaster Avenue
Malvern, Pennsylvania  19355-2143

Item 2(c).
Citizenship:
 
 
United States
 
Item 2(d).
Title of Class of Securities:
 
 
Common Stock, par value $.10 per share
 
Item 2(e).
CUSIP Number:
 
 
928298108
 
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
 
 
(a)
¨
Broker or Dealer Registered Under Section 15 of the Act (15 U.S.C. 78o)
 
 
(b)
¨
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c)
 
 
(c)
¨
Insurance Company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c)
 
 
(d)
¨
Investment Company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8)
 
 
(e)
¨
Investment Adviser in accordance with § 240.13d-1(b)(1)(ii)(E)
 
 
(f)
¨
Employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F)
 
 
(g)
¨
Parent Holding Company or control person in accordance with §240.13d-1(b)(ii)(G)
 
 
 
 
 
 
 
 
 
(h)
¨
Savings Association as defined in §3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813)
 
 
(i)
¨
Church plan that is excluded from the definition of an investment company under §3(c)(15) of the Investment Company Act of 1940 (15 U.S.C. 80a-3)
 
 
(j)
¨
Group, in accordance with §240.13d-1(b)(ii)(J)
 
Item 4.
Ownership.
 
 
(a)
Amount beneficially owned:  14,419,4711
 
 
(b)
Percent of class:  8.7%2
 
 
(c)
Number of shares as to which such person has:
 
 
(i)
Sole power to vote or to direct the vote: 6,419,3713
 
 
(ii)
Shared power to vote or to direct the vote:  8,000,1004
 
 
(iii)
Sole power to dispose or to direct the disposition of:  774,8895
 
 
(iv)
Shared power to dispose or to direct the disposition of:  8,000,1006
 
 
 
 
 
___________________________
 
1 Consists of 42,153 shares of common stock, 14,261,316 shares of class B common stock and 116,002 shares of common stock underlying currently exercisable options.  Each share of class B common stock is convertible into one share of common stock.  Does not include 1,159 shares of common stock held by Dr. Zandman’s spouse.  The class B common stock beneficially owned by Dr. Zandman includes 616,734 shares directly owned by Dr. Zandman, 8,000,100 shares held in family trusts, of which Dr. Zandman is the trustee and over which Dr. Zandman shares voting and dispositive control and 5,644,482 shares held in a voting trust, of which Dr. Zandman is the trustee and over which Dr. Zandman has sole voting control.  The shares held in a voting trust consist of 3,134,074 shares deposited by the Estate of Mrs. Luella B. Slaner and 2,510,408 shares deposited by Mrs. Slaner’s children and various trusts for the benefit of Mrs. Slaner’s children and grandchildren.  The voting trust agreement that governs the voting trust will remain in effect until the earlier of (x) February 1, 2050 or (y) the death or resignation or inability to act of Dr. Zandman, but will terminate at any earlier time upon the due execution and acknowledgment by the trustee of a deed of termination, duly filed with the registered office of the Company.
 
2 The class B common stock is entitled to 10 votes per share.  The shares beneficially owned by Dr. Zandman constitute approximately 48.5% of the outstanding voting power.
 
3 Consists of 42,153 shares of common stock and 616,734 shares of class B common stock owned directly by Dr. Zandman and 116,002 shares of common stock underlying currently exercisable options owned directly by Dr. Zandman and 5,644,482 shares of class B common stock held in a voting trust, of which Dr. Zandman is the trustee and over which Dr. Zandman has sole voting control.
 
4 Consists of 8,000,100 shares of class B common stock held in family trusts, of which Dr. Zandman is the trustee and over which Dr. Zandman shares voting and dispositive control.
 
5 Consists of 42,153 shares of common stock, 616,734 shares of class B common stock and 116,002 shares of common stock underlying currently exercisable options.
 
6 See footnote 4.
 
 
 
 
 
 
 
Item 5.
Ownership of Five Percent or Less of a Class.
 
 
Not applicable
 
Item 6.
Ownership of More than Five Percent on Behalf of Another Person.
 
 
Not applicable
 
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
 
 
Not applicable
 
Item 8.
Identification and Classification of Members of the Group.
 
 
Not applicable
 
Item 9.
Notice of Dissolution of Group.
 
 
Not applicable
 
Item 10.
Certification.
 
Not applicable
 
 
 

 
 
 

 
SIGNATURE
 
After reasonable inquiry and to the best knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this Statement is true, complete and correct.
 
January 14, 2011          
   Date
 
 
/s/ Dr. Felix Zandman
   Signature